Drug and Therapy Development for Triple Negative Breast Cancer

Drug and Therapy Development for Triple Negative Breast Cancer

139,00 €*

in Vorbereitung

A holistic view on TNBC that integrates the latest advances in the etiology, detection, diagnosis and treatment of this agressive cancer, laying the ground for the development of novel therapies.

HISTORY OF BREAST CANCER Early-Stage Diagnosis of Breast Cancer: Amelioration in ApproachesDNA replication stress and genome instability in breast cancerRecent advancement of nanotherapeutics to treat breast cancerHER Receptor in Breast CancerHuman endogenous retroviruses in triple negative breast cancerNOVEL DRUG DISCOVERY AND DEVELOPMENTDevelopment in Drug repurposing for the treatment of acute leukemia complicating metastatic breast cancerNovel pharmaceutical nanomaterials to advance the current breast cancer treatment - Current trends and future perspectiveADVANCED TECHNOLOGIES IN BREAST CANCER THERAPYArtificial intelligence-driven decisions in breast cancer diagnosisEstablishing nanotechnology-based drug development for triple-negative breast cancer treatmentEtiology and therapy of hormone receptor positive breast cancerDonor-acceptor based heterocyclic compounds as chemotherapy and photothermal agents in treatment of breast cancer cellREGULATORY, CLINICAL ASPECTS AND CASE STUDIES An insight into drug regulatory affairs and the proceduresA comprehensive review of some heat shock proteins in the development and progression of human breast cancerNanoparticle-based therapeutics for triple negative breast cancer
ISBN 9783527351756
Artikelnummer 9783527351756
Medientyp Buch
Copyrightjahr 2023
Verlag Wiley-VCH
Umfang 320 Seiten
Sprache Englisch